Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis
- 31 March 2008
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 7 (2) , 147-153
- https://doi.org/10.1016/j.jcf.2007.07.006
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Quality of Spirometry Test Performance in Children and Adolescents*Chest, 2000
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999
- The diagnosis of cystic fibrosis: A consensus statementThe Journal of Pediatrics, 1998
- Standardization of Spirometry, 1994 Update. American Thoracic Society.American Journal of Respiratory and Critical Care Medicine, 1995
- Selection of Spirometric Measurements in a Clinical Trial, the Lung Health StudyAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Spirometry in the Lung Health Study: II. Determinants of short-term intraindividual variability.American Journal of Respiratory and Critical Care Medicine, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Spirometry in the Lung Health Study: 1. Methods and Quality ControlAmerican Review of Respiratory Disease, 1991
- Relationship of lung function loss to level of initial function: correcting for measurement error using the reliability coefficient.Journal of Epidemiology and Community Health, 1988
- Quality control aspects of pulmonary function testing in the multiple risk factor intervention trialControlled Clinical Trials, 1986